Showing results (1641-1650 of 2,013) with videos related to

Sort By:
Pageof 202
Plos One|March 10, 2015
Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strainJoanna Seiffert, Farhana Hussain, Coen Wiegman, et al.
Nature Communications|April 7, 2020
CHD4 slides nucleosomes by decoupling entry- and exit-side DNA translocationYichen Zhong, Bishnu P Paudel, Daniel P Ryan, et al.
Plos One|September 29, 2017
Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoringTimothy P Ryan, Ryan D Morrison, Jeffrey J Sutherland, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 24, 2014
Adsorption of surfactant protein D from human respiratory secretions by carbon nanotubes and polystyrene nanoparticles depends on nanomaterial surface modification and sizeMagda Marchetti, Milo S P Shaffer, Martina Zambianchi, et al.
Frontiers in Immunology|February 8, 2024
Persistent CD8<sup>+</sup> T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markersStephanie M LaVergne, Taru S Dutt, Kim McFann, et al.
The Journal of Surgical Research|June 4, 2026
Diagnostic Outcomes of Robotic Bronchoscopy in a Multidisciplinary, Multi-Hospital Lung Nodule ProgramRachel L Deitz, John P Ryan, Thomas Rubino, et al.
Journal of Orthopaedics|December 9, 2024
Injection drug use is associated with repeat irrigation and debridement in native joint septic arthritisGabriel S Linden, Sophie E Lipson, Vineet Desai, et al.
Cancer|January 30, 2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan, Matthew H Kulke, Charles S Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancerMatthew H Kulke, Lawrence S Blaszkowsky, David P Ryan, et al.
Endocrine-Related Cancer|April 11, 2013
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumorsJ R Strosberg, J A Chan, D P Ryan, et al.
Pageof 202